Llwytho...
Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
BACKGROUND: Patients with triple negative breast cancer (TNBC) exhibit poor prognosis and are at high risk of tumour relapse, due to the resistance to chemotherapy. These aggressive phenotypes are in part attributed to the presence of breast cancer stem cells (BCSCs). Therefore, targeting BCSCs is a...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Br J Cancer |
|---|---|
| Prif Awduron: | , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Publishing Group UK
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6288167/ https://ncbi.nlm.nih.gov/pubmed/30482914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0287-3 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|